ARCHIVES

JCO Retracts Key Duke Genomics Paper; Duke Shuts Down Three Phase II Trials

This article is from The Cancer Letter archive.

Vol. 36 No. 42 | November 19, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Approves Votrient For Soft Tissue Sarcomas

April 27, 2012

Government Remains open Under Budget Agreement; New Deadlines Are Oct. 5 & 19

October 5, 1990

In Brief: Congress Corrects An Inequity; Califano Gets a Health Assistant – Fordham Of N.C.

March 25, 1977

NCI subsidy of $2 million paid major expenses of rescheduled meeting.

April 15, 2005

ACS Board To Consider Proposal For Implementing Cancer Response System Nationwide; Could End CIS

June 7, 1985

Faulding, NaPro In Agreement For Marketing Paclitaxel.

March 30, 2001